Martin Babler's Insider Trades & SAST Disclosures
Martin Babler's most recent trade in Alumis Inc. was a trade of 15,650 Common Stock done at an average price of $6.4 . Disclosure was reported to the exchange on April 1, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Martin Babler.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alumis Inc. | Martin Babler | Director, President, CEO and Chairman | Purchase of securities on an exchange or from another person at price $ 6.44 per share. | 01 Apr 2025 | 15,650 | 106,454 | - | 6.4 | 100,733 | Common Stock |
| Alumis Inc. | Martin Babler | Director, President, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 523,000 | 523,000 | - | - | Stock Option (Right to Buy) | |
| 89bio Inc | Martin Babler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 56,400 | 56,400 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Martin Babler | Director, President, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 534,759 | 534,759 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Martin Babler | Director, President, CEO and Chairman | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jun 2024 | 534,759 | 0 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Martin Babler | Director, President, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 478,288 | 478,288 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Martin Babler | Director, President, CEO and Chairman | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jun 2024 | 478,288 | 0 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Martin Babler | Director, President, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 380,852 | 380,852 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Martin Babler | Director, President, CEO and Chairman | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jun 2024 | 380,852 | 0 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Martin Babler | Director, President, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 263,101 | 263,101 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Martin Babler | Director, President, CEO and Chairman | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jun 2024 | 263,101 | 0 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Martin Babler | Director, President, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 245,989 | 245,989 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Martin Babler | Director, President, CEO and Chairman | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jun 2024 | 245,989 | 0 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Martin Babler | Director, President, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 241,210 | 241,210 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Martin Babler | Director, President, CEO and Chairman | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jun 2024 | 241,210 | 0 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Martin Babler | Director, President, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 107,028 | 107,028 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Martin Babler | Director, President, CEO and Chairman | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jun 2024 | 107,028 | 0 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Martin Babler | Director, President, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 106,951 | 106,951 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Martin Babler | Director, President, CEO and Chairman | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jun 2024 | 106,951 | 0 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Martin Babler | Director, President, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 90,804 | 90,804 | - | - | Common Stock | |
| Alumis Inc. | Martin Babler | Director, President, CEO and Chairman | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jun 2024 | 90,804 | 0 | - | - | Class A Common Stock | |
| Alumis Inc. | Martin Babler | Director, President, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 21,390 | 21,390 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Martin Babler | Director, President, CEO and Chairman | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jun 2024 | 21,390 | 0 | - | - | Stock Option (Right to Buy) | |
| Alumis Inc. | Martin Babler | Director, President, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 21,390 | 21,390 | - | - | Stock Option (Right to Buy) | |
| Prelude Therapeutics Inc | Martin Babler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 23,500 | 23,500 | - | - | Director Stock Option (Right to Buy) | |
| 89bio Inc | Martin Babler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2024 | 67,700 | 67,700 | - | - | Stock Option (Right to Buy) | |
| Prelude Therapeutics Inc | Martin Babler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 23,500 | 23,500 | - | - | Director Stock Option (Right to Buy) | |
| Neoleukin Therapeutics Inc | Martin Babler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Prelude Therapeutics Inc | Martin Babler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 31,293 | 31,293 | - | - | Director Stock Option (Right to Buy) | |
| Neoleukin Therapeutics Inc | Martin Babler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Prelude Therapeutics Inc | Martin Babler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2021 | 36,400 | 36,400 | - | - | Employee Stock Option (Right to Buy) | |
| Neoleukin Therapeutics Inc | Martin Babler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2021 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Neoleukin Therapeutics Inc | Martin Babler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Sep 2020 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges